Primary Hypoalphalipoproteinemia With Significant Premature Atherosclerosis

Area of Science:

• Cardiovascular Medicine
• Genetics
• Metabolic Disorders

Background:

• Primary hypoalphalipoproteinemia, characterized by low high-density-lipoprotein cholesterol (HDL-C), is often genetic.
• Low HDL-C is linked to increased atherosclerotic cardiovascular disease risk, though causality is debated.

Observation:

• A 37-year-old woman with severely low HDL-C and coronary artery disease was diagnosed with Tangier disease via genetic testing.
• Her lipid profile showed favorable non-high-density-lipoprotein (non-HDL) levels despite low HDL-C.

Findings:

• Clinical trials targeting low HDL-C have not demonstrated clear cardiovascular outcome benefits.
• This case suggests that even with optimal low-density-lipoprotein cholesterol (LDL-C), severely low HDL-C can be associated with significant cardiovascular disease.

Implications:

• Current lipid management guidelines prioritize total and LDL-C, potentially overlooking risks in patients with genetic hypoalphalipoproteinemia.
• Management for patients with genetic disorders causing low HDL-C and optimal LDL-C should focus on lifestyle modification and statin therapy.